Outlook for Indian banks is stable, says Moody’s, BFSI News, ET BFSI

[ad_1]

Read More/Less


Outlook for Indian banks is stable as a likely pick up in lending growth in a supportive policy environment is expected to drive credit cost down, Moody’s Investors Service said.

“Pickup in activity levels will drive credit growth, with positive effects to asset risks,” the global rating company said in a report on banks in the emerging market.

The report lauded India’s rising vaccination rates and selective use of restrictions that helped recovery in economic activity.

“Stable asset quality supported by gradual improvement in the job market and better corporate risk will help reduce credit costs as economic activity normalizes,” it said, adding that policy support for borrowers would limit asset quality deterioration.

The report projected a stable outlook for banks in the entire emerging market space, supported by continued recovery in economic activity, as well as banks’ solid balance sheets, including high levels of loan loss reserve, high profitability, strong liquidity and capital position, which will help mitigate near-term risks.

The stable sector outlook reflects Moody’s view of credit fundamentals in the emerging markets banks sector over the next 12 to 18 months.

In India, continued government support for public sector banks would be positive for loan growth, supported by new equity injections in 2022.

“Despite maintaining lower reserve buffers compared to private banks, public sector banks can withstand problem loans growth without materially eroding their buffers,” the report observed.

The rating company however emphasized concerns over stressed assets for the country’s small & medium enterprises and retail loan segments. Corporate loan quality is likely to be stable with policy support for borrowers limiting asset quality deterioration.

Emerging markets banks will maintain loan loss reserve buffers built in 2020 that will mitigate risks of a moderate increase in nonperforming loans, following the expiration of support measures, recent inflationary pressures in the region and the weak job markets in some countries, Moody’s associate managing director Ceres Lisboa said.

“We expect the G20 emerging market economies will continue to present a solid recovery of 4.8% in 2022 and 4.3% in 2023, on average, with operating conditions reaching pre-pandemic levels in most countries,” Lisboa was quoted as saying.

Meanwhile, Moody’s expected tightening of monetary policy by the Reserve Bank of India and central banks in LatAm, Russia and Turkey given the rising pressure on inflation, despite downside risks to growth with pronounced negative real yields.



[ad_2]

CLICK HERE TO APPLY

6 Stocks To Buy Into This Correction For Up To 37% Gains In 1-year

[ad_1]

Read More/Less


Investment

oi-Roshni Agarwal

|

Nifty on the new Covid variant worries collapsed last week by a great deal and in trade on November 30, 2021 is currently almost 8.5% percent down from its peak level of 18,604 scaled on October 19, 2021. Already the markets world over have been factoring an earlier than expected rate hike by the US Federal Reserve amid spiking inflationary levels.

“Due to the various global factors (Fed’s taper announcement, rising bond yields, higher crude oil prices, and strengthening of the US Dollar Index) and detection of a new COVID-19 variant – Omicron – in South Africa, Nifty has toppled sharply. A big fundraise in the primary market also put some pressure on the secondary market. Sentiments were battered globally, with global markets correcting by 2-3%, bond yields easing, and Brent Crude prices plunging by 11%. India’s VIX rallied 25% to 20.8.

Since these are early days for the new variant, limited information regarding its transmission and impact is available. We expect the Centre/ state governments to remain proactive, given their experience from the second COVID wave in Apr-May’21, and guidelines to evolve as the trajectory of the new variant becomes clearer. We expect the market to witness elevated volatility in the near term. However, valuations after the pullback, are relatively reasonable now at 23.3x/19.5x FY22E/FY23E Nifty EPS. Hence we would advise investors to buy into this correction. advise investors to buy into this correction”, says Mr. Siddhartha Khemka, Head – Retail Research, Motilal Oswal Financial Services Ltd.

Likewise, different brokerages have come up with ‘Buy’ recommendations from different sector for considerable gains in a 1-year period:

1. UPL:

1. UPL:

Jefferies has a ‘Buy’ on the scrip of UPL for a 1-year target price of Rs. 945. The ‘Buy’ has been retained given the various triggers including focus on margin accretive differentiated solutions, robust pricing, launch of new platforms and ESG could underpin its future growth.

2. IPCA Lab:

Motilal Oswal has a ‘Buy’ call on the pharma scrip for a 1-year price target of Rs. 2600. The brokerage is bullish on the counter given superior execution in branded generics exports, capacity expansion in API and better traction in the institutional anti-malarial segment.

3. PNC Infratech:

3. PNC Infratech:

This construction and contracting real estate entity has been given a ‘Buy’ call by Geojit for a price target of Rs. 370 to be realised in 1-year. The buy on the stock has been reiterated given the strong order book and a healthy balance sheet. The company’s Q2 revenue that scaled 53 percent YoY in the second quarter has been better than the estimates.

4. Escorts:

Emkay has given a buy on the tractor major for a target price of Rs. 2140 in the 1 year horizon. The stock has been upgraded to a ‘Buy’ as Kubota’s takeover would substantially improve the company’s medium term growth outlook; via technology support and using Escorts for meeting Kubota’s global component needs.

5. Dixon Technologies:

5. Dixon Technologies:

The electricals firm has been again upgraded to a ‘Buy’ by Anand Rathi for a 1-year price target of Rs. 5936. After becoming strong in Indian contract manufacturing, Dixon has global aspirations and is now targeting the global LED bulb market.

6. Blue Dart Express:

Nirmal Bang has maintained its buy call on the couriers company for a price target of Rs. 7776 apiece. As per the brokerage, the company’s market share has gained despite premium pricing by as much as 25% in comparison to peers owing to unbeatable record in safety and reliability.

Stock Brokerage firm 1-year target price Last traded price as on November 30, 2021 Potential upside
UPL Jefferies 945 690 37.00%
IPCA Motilal Oswal 2600 2116 23.00%
PNC Infratech Geojit 370 299 24.00%
Escorts Emkay 2140 1860 15.00%
Dixon Anand Rathi 5936 5068 17.00%
Bluedart Express Nirmal Bang 7776 6737 15.00%

Disclaimer:

Disclaimer:

The above stocks from different sectors are recommended by different brokerages for potential gains. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

This Pharma Stock Has A Potential +38% Return, Amid Down Equity Market: Emkay Global

[ad_1]

Read More/Less


Target Price

The Current Market Price (CMP) of Gland Pharma is Rs. 3608. The brokerage firm, Emkay Global has estimated a Target Price for the stock at Rs. 5000. Hence the stock is expected to give a 38.6% return, in a Target Period of 1 year.

Stock Outlook
Current Market Price (CMP) Rs. 3608
Target Price Rs. 5000
1 year returns 38.60%

Company performance

Company performance

The company’s net sales stood at Rs. 34,629 mn, in FY 2021, and Emkay Global is expecting Rs. 43,909 mn sales in FY22 and Rs. 55,798 mn sales in FY23. On the other hand, adjusted PAT was Rs. 9970 mn in FY 21; the firm is anticipating Rs. 12617 mn APAT in FY 22, and a Rs. 16101 mn APAT in FY 23. Emkay Global said, “The company retained its soft growth guidance (CAGR in mid-twenties), driven by mid to high-teens growth in the US. US growth will be driven by new products and existing products equally.”

Comments by Emkay Global

Comments by Emkay Global

The firm added, “We remain positive on Gland Pharma on the back of strong growth and visibility into profitability. We estimate revenue/EBITDA/net profit CAGRs of 25%/25%/27% (FY21-24e). Strong growth should also boost Gland’s industry-leading return ratios further.”

About the company

About the company

Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries. They operate primarily under a business-to-business (B2B) model.

Disclaimer

Disclaimer

The above stock was picked from the brokerage report of Emkay Global. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

Gen Z hardest hit professionally by the economic impact of Covid-19: Report

[ad_1]

Read More/Less


Generation Z has been hardest hit professionally by the economic impact of the Covid-19 pandemic, according to a new study by the ADPRI research Institute, called ‘People at Work 2021: A Global Workforce View.’

The report is based on ADP’s survey of more than 32,000 adult workers across 17 countries.

As per the report, over 78 per cent of the 18–24 year-old cohort said that their professional lives have been affected by the pandemic.

Also read: Chipping off the old block

The survey also found two in five (39 per cent) had lost jobs, were furloughed, or suffered a temporary layoff from their employer. Whereas 28 percent of workers of all ages said the same.

Generation Z also indicated they were twice as likely to have been impacted by the pandemic compared to those aged over 55, the oldest age bracket where 19 per cent of respondents lost a job, been furloughed or were temporarily laid off with the same employer.

“This may explain the plunge in optimism of 10 percentage points (83 per cent) among them,” the report said.

In comparison, 29 per cent of professionals in the 25-34 age bracket, 25 per cent aged between 35-44 and 21 per cent of the 45-54 cohort said that they lost a job, been furloughed or were temporarily laid off with the same employer.

Gen Z to be professionally agile

Rahul Goyal, Managing Director of ADP India & Southeast Asia, said Generation Z has had to be the most professionally agile of any age group in the face of Covid-19.

“In India, more than half of young workers say they have taken up additional responsibility for fear of job loss during the pandemic,” said Goyal.

“Employees often define job security by the reach of their professional network and the ability to tap into relationships to find non-linear jobs that can extend a career. That’s exactly what Generation Z is doing: finding new ways to climb the ladder,” Goyal said.

The report also highlighted the impact the pandemic has had on employees’ attitudes toward the current world of work, their expectations of and what they hope for in the workplace of the future.

In India, 89 per cent of the Generation Z mentioned that they had to choose between work and well-being or family.

“They attributed working from home to blurring the boundaries of definitive working hours,” it said.

“The unfortunate reality of entering the workforce in a recession is large initial earnings losses. This triggers significant changes to local labour market structures that can take years to recover from. The more young people can be proactive, the better,” Goyal said.

“Covid-19 has been an emotional burden for the younger generation of workers in India, but they see themselves getting better and stronger through self-motivation, adaptability, and new personal skills. This could have long-term implications for the jobs people do and how they work in the future,” Goyal further added.

[ad_2]

CLICK HERE TO APPLY

NBFC Agriwise Finserv partners Central Bank of India for agri loan disbursals

[ad_1]

Read More/Less


Agriwise Finserv Limited, an agri-focussed NBFC, has entered into a co-lending agreement with Central Bank of India for agri-loan disbursal.

Cash credit for agri sector should be brought on par with other biz: SBI Ecowrap

The co-lending agreement will ensure that the farmer, agri and allied community get finance at affordable rates in a simple, transparent and speedy manner. The loan will be disbursed at a blended interest rate, as per the RBI directive on co-lending of loans, the company said in a statement.

Agriwise to enlarge portfolio

Kalpesh Ojha, Chief Financial Officer, Agriwise, said, “It is a matter of great pride and prestige to partner with Central Bank of India in our journey towards sustainable financial solutions in rural India. We are committed to enlarging our portfolio to under-served and un-served rural customer segments and increasing our offerings to our current customers. We wish to leverage partnerships that bring together our strength of reach and customer insights with the banks lower cost of funds. In parallel, our strong technology backbone is helping us capture unique customer insights to deliver our product and solutions in a seamless, transparent and fair manner.”

Bank of Baroda launches centralised agri-loans processing units

Central Bank of India focus

Rajeev Puri, Executive Director, Central Bank of India, said, “We are focussed on lending to the agriculture sector as priority sector lending is a key goal to empower our farmer community. With this tie-up, we wish to reach a larger and deeper set of customers in the rural and agri-sector. Agriwise, with its specialised knowledge and experience in dealing with agri and allied sectors, will enable us to serve a broader set of customers.”

[ad_2]

CLICK HERE TO APPLY

Reverse repo hike to be split between Dec and Feb policy reviews: Acuité

[ad_1]

Read More/Less


With ongoing calibration of liquidity surplus acting as a precursor, Acuité Ratings and Research expects a hike in the reverse repo rate, which is likely to be split between December 2021 and February 2022 policy reviews.

The anticipated move in reverse repo rate from 3.35 per cent currently to 3.75 per cent by February 2022 would help restore the width of the policy rate corridor to its normal level of 25 basis points/bps (with repo rate being maintained at 4 per cent) from the current spread of 65 bps, the credit rating agency said in a report.

“Having said that, we remain watchful of the risks emerging from the fresh resurgence of Covid cases in Europe and Africa along with the uncertainty on the impact of the new variant (Omicron),” it said.

“This has the potential to reverse the ongoing travel liberalisation and can possibly dampen global growth prospects. This can also reinforce the “wait and watch” approach of RBI, thereby slowing down the progress on its policy normalization path,” Acuité said.

The LAF corridor effectively defines the operating procedure of monetary policy, with the marginal standing facility (MSF) as the upper bound (ceiling), the fixed overnight reverse repo rate as the lower bound (floor) and the policy repo rate in between.

Expect rise in yields

Suman Chowdhury, Chief Analytical Officer, Acuité, observed that from the bond yield perspective, while yields at the shorter end of the curve are poised to remain firm amidst growing expectations of central bank accelerating its policy normalisation, the 10-year government security (G-Sec) yields are expected to average towards 6.5 per cent by March 2022.

The report noted that after bottoming out at 5.97 per cent in May 2021, India’s 10-year G-Sec yield has been gradually creeping up with bond yields averaging at 6.35 per cent in November 2021, the highest since the beginning of the pandemic.

Since the start of H2FY22, the 10-year G-Sec yield has moved up by a cumulative 18 bps. One basis point is equal to one-hundredth of a percentage point.

The agency assessed that the impact on the shorter end of the curve has been more pronounced as yields on 1-3 year maturity government bonds jumped by about 20-50 basis points during the same period.

Effect of commodity price hike

While there has been relief from concerns over additional government borrowing in H2FY22 along with the moderation in inflation trajectory, the firmness in the yields is largely a reflection of a steep rise in global commodity and crude oil prices along with commencement of liquidity normalisation by the RBI since the last MPC, the agency said.

The rise in short term g-sec yield has been in focus as this is an outcome of active calibration of money market liquidity by the RBI.

“Acuité believes that monetary policy normalisation will continue in the major global economies given the extended period of higher inflation but the speed may vary across the central banks, depending upon their assessment of the residual pandemic risks,” it said.

“India is also expected to continue with the gradual approach to normalization and a phase-wise increase in the reverse repo rate can be envisaged in the current fiscal,” Chowdhury said,

The central bank in its last MPC meeting had augmented its liquidity calibration effort through the expansion of the scope of VRRR (variable reverse repo rate) auctions along with discontinuation of the government bond acquisition programme (G-SAP).

[ad_2]

CLICK HERE TO APPLY

Supreme Court stays notice by UP police on Yes Bank in Dish TV case

[ad_1]

Read More/Less


The Supreme Court on Tuesday has stayed a notice by the Uttar Pradesh policy on Yes Bank from exercising its voting rights in the Dish TV annual general meeting.

This is a big relief to the private sector lender who can now participate in the AGM of Dish TV, which is being held today.

The bank had filed a petition with the Supreme Court against the decision of the Allahabad High Court, which had dismissed its plea on de-freezing of voting rights.

Yes Bank is the largest shareholder of Dish TV with about 25 per cent stake. It had earlier called for an EGM for removal of Dish TV’s Managing Director Jawahar Goel and four other directors and also the appointment of new directors on the grounds that the current board had approved a rights issue merely to dilute the bank’s shareholding and was not following good corporate governance norms.

[ad_2]

CLICK HERE TO APPLY

S&P, BFSI News, ET BFSI

[ad_1]

Read More/Less


Earnings of Indian banks will get a boost from easing non-performing loans and the nation’s economic recovery that will drive demand for credit.

Many large banks saw their nonperforming loan ratios decline “as new NPA formation was more than offset by recoveries on retail loans,” said Nikita Anand, an analyst at S&P Global Ratings, after both private-sector and government-owned banks reported an improvement in overall asset quality in the fiscal second quarter that ended Sept. 30. “[The banks’] earnings have improved with credit costs moderating,” he said.

As on September 30, the weak loan ratio peaked close to 10 per cent. Credit costs, which reflect provisioning on bad loans, will also likely hit their lowest level in 7 years. This in turn should boost earnings, according to S&P.

State Bank of India, the country’s largest bank by assets, reported total NPAs of Rs 1.25 lakh crore for the quarter ended September 30, down from Rs 1.36 lakh crore in the previous quarter and Rs 1.27 lakh crore in the same period a year ago. Bank of Baroda and Punjab National Bank also saw quarter-over-quarter falls in NPAs.

Meanwhile, the ratings agency said that it is sceptical of allowing corporate ownership in banks, given India’s weak corporate governance. Corporate ownership of banks raises risks of intergroup lending, diversion of funds and reputational exposure, it said. Currently, the Reserve Bank of India refrained from allowing corporate ownership in banks.

Better asset quality, economic rebound brighten Indian banks' earnings outlook: S&P

Economy on mend

India’s economy grew 20.1% year over year in the April-to-June quarter, recovering from a 24.4% contraction in the same period of 2020 when the COVID-19 pandemic forced a strict lockdown across the country. The Reserve Bank of India expects the economy to grow about 9.5% in the fiscal year to March 2022, and Governor Shaktikanta Das on November 16 underscored the “need for sustained impetus so that growth could return to, or better still, exceed the pre-pandemic trend.”

The rating agency said that the economy’s expansion is expected to outpace that of developing market peers in the coming few years. “In comparison, some tourism-dependent countries, such as Thailand, are likely to see long-term scarring as we expect only a gradual resumption of travel-related industries,” they agency said.

Ahead of the Diwali festive season, gross bank credit grew 6.7% year over year in both August and September, reversing a contraction earlier in the year, central bank data show.

“With cash flows improving for underlying borrowers due to easing of the pandemic and lockdowns, most banks have reported an improvement in asset quality and reduction in nonperforming assets,” said Krishnan Sitaraman, senior director at Crisil, a unit of S&P Global Inc.

“It is also a reflection of the clear improvement in economic fundamentals for the country” after the economy contracted 7.3% in the year that ended March 31, 2021, Sitaraman said.

Banks are likely to sustain their earnings improvement in 2022 if credit costs continue to moderate, though Sitaraman flagged the risk of a possible fresh wave of Covid infections and its potential impact on economic activity.

Better asset quality, economic rebound brighten Indian banks' earnings outlook: S&P

Better earnings

The net profit of State Bank of India in the second quarter rose to Rs 8,890 crore from Rs 5,246 crore in the prior-year period. ICICI Bank Ltd’s net profit increased to Rs 6,092 crore from Rs 4,882 crore in the prior-year period.

SBI’s credit cost and net interest margin profile were better than expectations, ICICI Securities said in a note after the lender reported its earnings. SBI’s management expects an opportunity to grow its corporate and small business portfolios as economic activity picks up, the merchant banking and retail broking arm of India’s second-biggest private-sector lender by assets said in a note. “SBI also has sufficient capital and liquidity on balance sheet to support growth.”

HDFC Bank, the country’s largest private-sector bank, saw its NPLs ease to Rs 21,000 crore from Rs 23,000 crore in the first quarter. The lender said its bad loans from small-and-medium scale businesses declined over the previous quarter and the corporate book is resilient, suggesting that a bigger part of incremental delinquency is flowing from the retail and agriculture segments, ICICI Securities said in a note after HDFC reported its earnings.

“Further curtailment of slippages, better recoveries and improved collections will support asset quality trends in coming quarters [for HDFC Bank],” according to ICICI Securities.



[ad_2]

CLICK HERE TO APPLY

Star Health raises Rs 3,217 cr from anchor investors ahead of IPO, BFSI News, ET BFSI

[ad_1]

Read More/Less


New Delhi, Star Health and Allied Insurance Company on Monday said it has raised a little over Rs 3,217 crore from anchor investors ahead of its IPO on Tuesday. The company has decided to allocate a total of 3,57,45,901 equity shares to 62 anchor investors at Rs 900 apiece, aggregating to Rs 3,217.13 crore, according to a circular uploaded on BSE website.

Monetary Authority of Singapore, Government of Singapore, Abu Dhabi Investment Authority, Morgan Stanley Asia (Singapore) Pte, Goldman Sachs (Singapore) Pte, BNP Paribas Arbitrage and Societe Generale are among the anchor investors.

In addition, SBI Life Insurance Company, HDFC Life Insurance Company and Edelweiss Mutual Fund have been allocated shares.

The initial public offering (IPO) comprises fresh issue of equity shares worth Rs 2,000 crore and an offer for sale of up to 58,324,225 equity shares by promoters and existing shareholders.

Those offering shares through the offer for sale are promoter and promoter group — Safecrop Investments India LLP, Konark Trust, MMPL Trust— and existing investors Apis Growth 6 Ltd, Mio IV Star, University of Notre Dame Du Lac, Mio Star, ROC Capital Pty Ltd, Venkatasamy Jagannathan, Sai Satish and Berjis Minoo Desai.

The public offer includes a reservation of shares worth Rs 100 crore for employees.

The issue, with a price band of Rs 870-900 a share will open for public subscription between November 30 and December 2.

At the upper end of the price band, the initial share-sale is expected to fetch Rs 7,249.18 crore.

Proceeds from the fresh issue would be used to augment the company’s capital base.

About 75 per cent of the issue size has been reserved for qualified institutional buyers (QIBs), 15 per cent for non-institutional investors and the remaining 10 per cent for retail investors.

Investors can bid for a minimum of 16 equity shares and in multiples thereof.

Star Health, leading private health insurer in the country, is owned by a consortium of investors like Westbridge Capital and Rakesh Jhunjhunwala.

At present, SBI Life Insurance Company, HDFC Life Insurance Company, ICICI Prudential Life Insurance Company and ICICI Lombard General Insurance Company are the few insurance companies which are listed on the stock exchanges.

Kotak Mahindra Capital Company, Axis Capital, BofA Securities India, Citigroup Global Markets India, ICICI Securities, CLSA India, Credit Suisse Securities (India) Private Limited, Jefferies India, Ambit, DAM Capital Advisors and IIFL Securities are the merchant bankers to the issue.

The equity shares of the company will be listed on the BSE and NSE.



[ad_2]

CLICK HERE TO APPLY

CAG flags treatment of bank recap expenditure in FY18-19, BFSI News, ET BFSI

[ad_1]

Read More/Less


The Comptroller and Audit General (CAG) has raised its concerns over treatment of expenditure of bank recapitalisation during 2017-18 and 2018-19, stating that it was against the provisions of the fiscal responsibility and Budget Management (FRBM) Act.

For recapitalisation of state-run banks, the government provided ₹80,000 crore in 2017-18 and of ₹1.06 lakh crore in 2018-19 respectively.

The CAG has flagged in the expenditure budget the above mentioned expenditure on recapitalisation of the PSBs, had been netted against receipts from issue of special securities, while in the receipt budget, receipts from the securities have been netted against expenditure on recapitalisation.

It said that during the two financial years, funds for these investments were raised by the government through issue of non-transferable special securities to the same PSBs.

According to CAG, the finance ministry had stated that bank recapitalisation was not fiscally neutral but cash neutral, as issue of securities would get reflected in the total government debt and coupon payments for the special securities when made would be reflected in the deficit of the relevant year.

The concept of recapitalisation bonds was first introduced in 2017. Earlier, the capital infusion was to done by the government to a bank through cash outgo from the Consolidated Fund of India led to fiscal pressure.In 2017, the government had introduced recap bonds.

Under this, the government issues recapitalisation bonds to a public sector bank which needs capital. In turn, banks subscribe to the bond against which the government receives the money. Now the money received goes as equity capital of the bank. So the government doesn’t have to pay anything from its pocket.

The national auditor also pointed out the deficit in operation of the National Small Savings Fund (NSSF), which comprises all collections of small saving schemes.

“The balances under NSSF do not explicitly disclose the substantial accumulated deficit in the fund, which would have to be made good by the government in the future. There is also inadequate disclosure that significant amounts were being provided from NSSF for funding revenue expenditure of the government which would have to be serviced through budgetary support. It also raised concerns over inadequacies in disclosure under the FRBM rules.

The CAG pulled up the union government for adopting an erroneous process of devolution of Integrated Goods and Services Tax to states and short-transfer of cesses to reserve funds, which resulted in under-reporting of deficit figures for the 2017-18 and 2018-19 fiscals. The IGST, which is levied on inter-state sale of goods and services, is shared between the Centre and states in the 50:50 ratio.

In its report on the union government accounts tabled in Parliament, the Comptroller and Auditor General of India (CAG) found that ₹13,944 crore was left unapportioned and retained in the Consolidated Fund of India (CFI) in 2018-19, even though the amended IGST Act now provides for a process for ad-hoc apportionment of IGST.



[ad_2]

CLICK HERE TO APPLY

1 19 20 21 22 23 16,279